156 related articles for article (PubMed ID: 34523746)
41. [Advances in research on antischistosomal drugs].
Qiu SJ; Xia CM
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
[TBL] [Abstract][Full Text] [Related]
42. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
43.
Guerra RA; Silva MP; Silva TC; Salvadori MC; Teixeira FS; de Oliveira RN; Rocha JA; Pinto PLS; de Moraes J
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559137
[TBL] [Abstract][Full Text] [Related]
44. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
Abo-Ghalia MH; Soliman AE
Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
[TBL] [Abstract][Full Text] [Related]
46. Drug resistance to schistosomicides and other anthelmintics of medical significance.
Brindley PJ
Acta Trop; 1994 Mar; 56(2-3):213-31. PubMed ID: 8203304
[TBL] [Abstract][Full Text] [Related]
47. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives.
Eweas AF; Allam G; Abuelsaad AS; ALGhamdi AH; Maghrabi IA
Bioorg Chem; 2013 Feb; 46():17-25. PubMed ID: 23247256
[TBL] [Abstract][Full Text] [Related]
49. The antischistosomal activity of oltipraz.
Bueding E; Dolan P; Leroy JP
Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):293-303. PubMed ID: 7134632
[TBL] [Abstract][Full Text] [Related]
50. 'Death and axes': unexpected Ca²⁺ entry phenologs predict new anti-schistosomal agents.
Chan JD; Agbedanu PN; Zamanian M; Gruba SM; Haynes CL; Day TA; Marchant JS
PLoS Pathog; 2014 Feb; 10(2):e1003942. PubMed ID: 24586156
[TBL] [Abstract][Full Text] [Related]
51. New evidence for tamoxifen as an antischistosomal agent:
Silva TC; Mengarda AC; Silva BC; Relvas-Lima TS; Rodrigues VC; Salvadori MC; Teixeira FS; Lopes AF; Rando DG; Moraes J
Future Med Chem; 2021 Jun; 13(11):945-957. PubMed ID: 33896196
[No Abstract] [Full Text] [Related]
52. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.
Xiao SH; Keiser J; Chollet J; Utzinger J; Dong Y; Endriss Y; Vennerstrom JL; Tanner M
Antimicrob Agents Chemother; 2007 Apr; 51(4):1440-5. PubMed ID: 17283188
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, biological evaluation, and structure-activity relationship of clonazepam, meclonazepam, and 1,4-benzodiazepine compounds with schistosomicidal activity.
Menezes CM; Rivera G; Alves MA; do Amaral DN; Thibaut JP; Noël F; Barreiro EJ; Lima LM
Chem Biol Drug Des; 2012 Jun; 79(6):943-9. PubMed ID: 22321778
[TBL] [Abstract][Full Text] [Related]
54. Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
Leban J; Kralik M; Mies J; Baumgartner R; Gassen M; Tasler S
Bioorg Med Chem Lett; 2006 Jan; 16(2):267-70. PubMed ID: 16246558
[TBL] [Abstract][Full Text] [Related]
55. Derivatives of biarylalkyl carboxylic acid induce pleiotropic phenotypes in adult Schistosoma mansoni in vitro.
Blohm AS; Mäder P; Quack T; Lu Z; Hahnel S; Schlitzer M; Grevelding CG
Parasitol Res; 2016 Oct; 115(10):3831-42. PubMed ID: 27230017
[TBL] [Abstract][Full Text] [Related]
56. Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives.
Hansen FK; Khankischpur M; Tolaymat I; Mesaros R; Dannhardt G; Geffken D
Bioorg Med Chem Lett; 2012 Aug; 22(15):5031-4. PubMed ID: 22749420
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
[TBL] [Abstract][Full Text] [Related]
59. Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni.
Long T; Neitz RJ; Beasley R; Kalyanaraman C; Suzuki BM; Jacobson MP; Dissous C; McKerrow JH; Drewry DH; Zuercher WJ; Singh R; Caffrey CR
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004356. PubMed ID: 26751972
[TBL] [Abstract][Full Text] [Related]
60.
Biendl S; Häberli C; Chen G; Wang W; Zhong L; Saunders J; Pham T; Wang X; Wu J; Charman SA; Vennerstrom JL; Keiser J
ACS Infect Dis; 2023 Mar; 9(3):643-652. PubMed ID: 36794836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
